Neuralstem, Inc.
Neuralstem, Inc. Reports Third Quarter Financial Results and Provides Business Update
Published in Medical Patent Week, December 6th, 2009
For the third quarter of 2009, the Company reported a net loss of $5,096,983, or $0.15 per share, compared with a net loss of $3,177,957 or $0.10 per share, for the comparable 2008 period. The increase was due to a non-cash charge related to a change in accounting for certain warrants, offset in part by reductions in other expense categories. Net loss attributable to common stockholders for the first nine months of 2009 was $7,380,751 or $0.22 per share, compared with $8,410,081, or $0.26 per share, for the comparable period in 2008, resulting...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Week
Source: Medical Patent Week (2009-12-06)
More Articles from Medical Patent Week
- American Biotech Labs, Llc
American Biotech Labs Receives FDA Clearance for New Prescription Wound Dressing Gel - American Heart Association
American Heart Association Late-breaking Clinical Trial Report: Risks of Anemia Drug Outweigh Benefits in Cardiovascular Disease Patients With Diabetes and Kidney Disease - Apieron, Inc.
Apieron Alleges Evidence Shows Aerocrine Inventors Withheld Prior Art Information from Patent Office - Article One Partners
Article One Partners Becomes World's Largest Patent Validation Firm - Bioscience
Hungarian Cancer Formula Producer Questions U.S. Introduction of AveUltra - Diabetic Retinopathy
Sales of Therapies to Treat Diabetic Retinopathy, Diabetic Neuropathy and Diabetic Nephropathy Will Increase by More Than 70 Percent Through 2018 - More from this issue of Medical Patent Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
